High-performance liquid chromatographic assay with fluorescence detection for the routine monitoring of the antidepressant mirtazapine and its demethyl metabolite in human plasma
- 1 January 1999
- journal article
- clinical trial
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 721 (2) , 309-316
- https://doi.org/10.1016/s0378-4347(98)00460-5
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Pharmacokinetics and Biotransformation of Mirtazapine in Human VolunteersClinical Drug Investigation, 1998
- Pharmacokinetics of mirtazapine from orally administered tablets: influence of a high-fat mealEuropean Journal of Drug Metabolism and Pharmacokinetics, 1997
- Mirtazapine Pharmacokinetics with Two Dosage Regimens and Two Pharmaceutical FormulationsPharmaceutical Research, 1997
- Pharmacokinetics of Mirtazapine from Orally Administered Tablets: Influence of Gender, Age and Treatment RegimenHuman Psychopharmacology: Clinical and Experimental, 1996
- MirtazapineCNS Drugs, 1996
- Bioavailability of mirtazapine from Remeron® tablets after single and multiple oral dosingHuman Psychopharmacology: Clinical and Experimental, 1995
- Pharmacokinetic dose-proportionality study at steady state of mirtazapine from Remeron® tabletsHuman Psychopharmacology: Clinical and Experimental, 1995
- Capillary gas chromatographic assay for the routine monitoring of the antidepressant mepirzepine in human plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1987